ArticlePsychiatry and clinical psychopharmacology2025
A Cross-Sectional Study on the Drug Use of Insomnia in a Chinese Medicine Hospital in Shenzhen.
Article in Psychiatry and clinical psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prevalence of insomnia disorder is high among the general poulation and is a risk factor for many diseases. The rationality of drug use for insomnia in Chinese Medicine Hospital was uncertain. In order to evaluate the use of drugs in the Chinese Medicine Hospital of Longgang, Shenzhen, the authors conducted this cross-sectional research. Methods: A retrospective, cross-sectional study was conducted in Shenzhen Hospital of Beijing University of Chinese Medicine (Long Gang), Guangdong Province. Insomnia patients from January 1, 2016, to November 10, 2020, were included in the cross-sectional study. Patients corresponding to International Classification of Sleep Disorders (ISCD-3) Diagnostic Criteria for short-term and chronic insomnia were included. The authors excluded patients with severe mental disease or nervous system dysfunction or who could not correctly describe their symptoms. The characteristics of insomnia patients, survey results of drug use and symptoms of insomnia patients were collected. The authors analyzed the basic information, condition of drug use, and relationship between symptoms and drug use using R software (version 4.0.2) with the arulesViz package. Results: A total of 9439 patients were included in the study. The average age of these patients was 45.81 years (SD 13.97 years). Anxiety, dreaminess, dizziness, palpitation, headache, thirst, weakness, chest distress, annoyance, abdominal distension, bad moods, difficulty in falling asleep and bitter taste in the mouth were core symptoms of insomnia. The 10 most commonly used drugs ranged from more to less were estazolam (29.99%), Zaoren anshen capsule (15.50%), oryzanol (14.82%), diazepam (14.51%), flupentixol and melitracen (14.30%), alprazolam (8.12%), zolpidem tartrate (5.29%), vitamin B6 (4.76%), sertraline (4.03%), and clonazepam (2.97%). Conclusion: Drugs used for insomnia in the Chinese medicine hospital in Longgang, Shenzhen mainly included benzodiazepines, nonbenzodiazepines, Chinese patent medicines, anti-anxiety drugs, anti-depression drugs, oryzanol, and vitamin B6. The use of oryzanol and vitamin B6 was abused in Chinese medicine hospitals, and the use of Chinese medicine should be evaluated more rigorously. Nonbenzodiazepines should be promoted and more widely understood in the Chinese medicine hospital in Longgang, Shenzhen.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.